Literature DB >> 34196307

Neurodegenerative disorders and gut-brain interactions.

Alpana Singh1, Ted M Dawson2,3,4,5,6, Subhash Kulkarni1.   

Abstract

Neurodegenerative disorders (NDs) affect essential functions not only in the CNS, but also cause persistent gut dysfunctions, suggesting that they have an impact on both CNS and gut-innervating neurons. Although the CNS biology of NDs continues to be well studied, how gut-innervating neurons, including those that connect the gut to the brain, are affected by or involved in the etiology of these debilitating and progressive disorders has been understudied. Studies in recent years have shown how CNS and gut biology, aided by the gut-brain connecting neurons, modulate each other's functions. These studies underscore the importance of exploring the gut-innervating and gut-brain connecting neurons of the CNS and gut function in health, as well as the etiology and progression of dysfunction in NDs. In this Review, we discuss our current understanding of how the various gut-innervating neurons and gut physiology are involved in the etiology of NDs, including Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis, to cause progressive CNS and persistent gut dysfunction.

Entities:  

Mesh:

Year:  2021        PMID: 34196307      PMCID: PMC8245172          DOI: 10.1172/JCI143775

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  214 in total

1.  Modulation of neuroinflammation and memory dysfunction using percutaneous vagus nerve stimulation in mice.

Authors:  William J Huffman; Saraswathi Subramaniyan; Ramona M Rodriguiz; William C Wetsel; Warren M Grill; Niccolò Terrando
Journal:  Brain Stimul       Date:  2018-10-09       Impact factor: 8.955

Review 2.  The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.

Authors:  Jessica Y Vargas; Clara Grudina; Chiara Zurzolo
Journal:  Ageing Res Rev       Date:  2019-01-25       Impact factor: 10.895

Review 3.  Pathology of Neurodegenerative Diseases.

Authors:  Brittany N Dugger; Dennis W Dickson
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-07-05       Impact factor: 10.005

Review 4.  Nonmotor symptoms in Parkinson's disease.

Authors:  Mark Stacy
Journal:  Int J Neurosci       Date:  2011       Impact factor: 2.292

5.  Loss of nitrergic and cholinergic neurons in the enteric nervous system of APP/PS1 transgenic mouse model.

Authors:  Xiaolei Han; Shi Tang; Lingling Dong; Lin Song; Yi Dong; Yongxiang Wang; Yifeng Du
Journal:  Neurosci Lett       Date:  2017-01-27       Impact factor: 3.046

6.  Motor disorder in Huntington's disease begins as a dysfunction in error feedback control.

Authors:  M A Smith; J Brandt; R Shadmehr
Journal:  Nature       Date:  2000-02-03       Impact factor: 49.962

7.  Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.

Authors:  Jacob Horsager; Katrine B Andersen; Karoline Knudsen; Casper Skjærbæk; Tatyana D Fedorova; Niels Okkels; Eva Schaeffer; Sarah K Bonkat; Jacob Geday; Marit Otto; Michael Sommerauer; Erik H Danielsen; Einar Bech; Jonas Kraft; Ole L Munk; Sandra D Hansen; Nicola Pavese; Robert Göder; David J Brooks; Daniela Berg; Per Borghammer
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

Review 8.  Parkinson's disease and anxiety.

Authors:  K Walsh; G Bennett
Journal:  Postgrad Med J       Date:  2001-02       Impact factor: 2.401

Review 9.  Gastrointestinal dysfunction in amyotrophic lateral sclerosis.

Authors:  M Toepfer; C Folwaczny; A Klauser; R L Riepl; W Müller-Felber; D Pongratz
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  1999-12

10.  Intestinal microbial dysbiosis aggravates the progression of Alzheimer's disease in Drosophila.

Authors:  Shih-Cheng Wu; Zih-Syuan Cao; Kuo-Ming Chang; Jyh-Lyh Juang
Journal:  Nat Commun       Date:  2017-06-20       Impact factor: 14.919

View more
  9 in total

1.  Experimental Colitis Enhances Temporal Variations in CX3CR1 Cell Colonization of the Gut and Brain Following Irradiation.

Authors:  Ayush Batra; Triet M Bui; Jacob F Rehring; Lenore K Yalom; William A Muller; David P Sullivan; Ronen Sumagin
Journal:  Am J Pathol       Date:  2021-11-10       Impact factor: 4.307

Review 2.  An Outlook on the Complexity of Protein Morphogenesis in Health and Disease.

Authors:  Maurizio Brunori; Stefano Gianni
Journal:  Front Mol Biosci       Date:  2022-06-13

Review 3.  Guts Imbalance Imbalances the Brain: A Review of Gut Microbiota Association With Neurological and Psychiatric Disorders.

Authors:  Laura Mitrea; Silvia-Amalia Nemeş; Katalin Szabo; Bernadette-Emőke Teleky; Dan-Cristian Vodnar
Journal:  Front Med (Lausanne)       Date:  2022-03-31

Review 4.  Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics.

Authors:  Manqiu Ding; Yue Lang; Hang Shu; Jie Shao; Li Cui
Journal:  Front Immunol       Date:  2021-10-11       Impact factor: 7.561

5.  Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db Mice.

Authors:  Tatiana A Korolenko; Nina I Dubrovina; Marina V Ovsyukova; Nataliya P Bgatova; Michael V Tenditnik; Alexander B Pupyshev; Anna A Akopyan; Natalya V Goncharova; Chih-Li Lin; Evgeny L Zavjalov; Maria A Tikhonova; Tamara G Amstislavskaya
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

6.  Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain.

Authors:  Jennifer Kim; Sebastian W Ahn; Kyle Deans; Devon Thompson; Benjamin Ferland; Prajan Divakar; Christine Dominas; Oliver Jonas
Journal:  Front Bioeng Biotechnol       Date:  2022-03-18

Review 7.  α-Synuclein Conformational Plasticity: Physiologic States, Pathologic Strains, and Biotechnological Applications.

Authors:  Amanda Li; Cyrus Rastegar; Xiaobo Mao
Journal:  Biomolecules       Date:  2022-07-17

8.  Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.

Authors:  Guanghui Cui; Shaojie Li; Hui Ye; Yao Yang; Qiuyue Huang; Yingming Chu; Zongming Shi; Xuezhi Zhang
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

9.  Gut Serotonin as a General Membrane Permeability Regulator.

Authors:  Noémi Császár; Istvan Bókkon
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.